911825-56-4 Usage
Description
(E)-5-fluoro-3,4-dihydronaphthalen-1(2H)-one oxime, also known as FDN-1, is a compound derived from fluoro-naphthalene. It is an oxime derivative, which means it contains a nitrogen atom attached to a carbon atom with a double bond. FDN-1 has been studied for its potential pharmaceutical applications, particularly as a neuroprotective agent. Its structural properties and chemical reactivity make it a promising candidate for further drug development, particularly in the treatment of neurological disorders. Additionally, its unique structure also makes it a valuable building block for the synthesis of other organic compounds. Overall, FDN-1 is a compound of interest for both its potential therapeutic applications and its role in organic synthesis.
Uses
Used in Pharmaceutical Industry:
(E)-5-fluoro-3,4-dihydronaphthalen-1(2H)-one oxime is used as a neuroprotective agent for its potential therapeutic applications in the treatment of neurological disorders. Its structural properties and chemical reactivity contribute to its promise as a candidate for further drug development in this area.
Used in Organic Synthesis:
(E)-5-fluoro-3,4-dihydronaphthalen-1(2H)-one oxime is used as a valuable building block for the synthesis of other organic compounds due to its unique structure, which can be utilized in various chemical reactions and processes to create a range of different products.
Check Digit Verification of cas no
The CAS Registry Mumber 911825-56-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,1,8,2 and 5 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 911825-56:
(8*9)+(7*1)+(6*1)+(5*8)+(4*2)+(3*5)+(2*5)+(1*6)=164
164 % 10 = 4
So 911825-56-4 is a valid CAS Registry Number.
911825-56-4Relevant articles and documents
Triazole derivative having HSP90 (Heat Shock Protein) inhibiting activity, as well as preparation method and application of triazole derivative
-
Paragraph 0590; 0591; 0592; 0593, (2017/08/02)
The invention discloses a triazole derivative having an HSP90 (Heat Shock Protein) inhibiting activity, as well as a preparation method and an application of the triazole derivative. Specifically, the invention relates to the triazole derivative having a structure as shown in a formula (I), a stereisomer of the triazole derivative and a pharmaceutically acceptable salt, wherein the definition of each substituent group in the formula (I) and the definition in a description are the same. The compound with a novel structure has the HSP90 inhibiting activity, can be used to cure cancers, neurodegenerative disorders, inflammation diseases, autoimmune diseases, ischemic brain injuries and the like, and has a broad application prospect.
7-Substituted Purine Derivatives for Immunosuppression
-
, (2008/12/05)
The present invention provides novel purinone and related derivatives useful for the prevention and treatment of autoimmune diseases, inflammatory disease, mast cell mediated disease and transplant rejection. The compounds are of the general formula III:
